Ultragenyx Pharmaceutical Inc.
RARE
$29.65
-$0.66-2.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.17% | 19.99% | 5.69% | 37.42% | 38.38% |
| Total Receivables | 17.62% | 2.38% | 65.93% | 19.38% | 48.69% |
| Inventory | 15.85% | 28.20% | 32.49% | 36.26% | 42.05% |
| Prepaid Expenses | -- | -- | -28.81% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -82.76% | -82.16% | 238.94% | 2,615.84% | 2,989.62% |
| Total Current Assets | -25.38% | 17.31% | 11.60% | 33.45% | 37.39% |
|
|
|||||
| Total Current Assets | -25.38% | 17.31% | 11.60% | 33.45% | 37.39% |
| Net Property, Plant & Equipment | -8.23% | -8.49% | -7.33% | -15.71% | -9.57% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 5.11% | 6.96% | 7.24% | 4.86% | 5.06% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.81% | 4.01% | 10.05% | 93.12% | 103.00% |
| Total Assets | -19.29% | 0.37% | 0.83% | 24.25% | 23.42% |
|
|
|||||
| Total Accounts Payable | -42.75% | 15.81% | -7.97% | 7.89% | 42.01% |
| Total Accrued Expenses | 17.08% | 16.01% | 22.64% | 3.59% | -7.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 28.98% | 22.34% | 43.76% | 40.85% | 69.43% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.47% | 18.77% | 22.72% | 12.22% | 11.66% |
|
|
|||||
| Total Current Liabilities | 7.47% | 18.77% | 22.72% | 12.22% | 11.66% |
| Long-Term Debt | -7.05% | -6.44% | -4.93% | -5.29% | -4.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.70% | -0.69% | -1.74% | -31.54% | 73.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.86% | 5.94% | 11.54% | 10.23% | 7.60% |
| Total Liabilities | -3.21% | -0.53% | 2.10% | -1.81% | 0.32% |
|
|
|||||
| Common Stock & APIC | 6.09% | 14.96% | 15.03% | 26.41% | 27.39% |
| Retained Earnings | -14.44% | -15.44% | -16.80% | -17.12% | -18.85% |
| Treasury Stock & Other | 75.53% | 20.88% | -199.38% | 139.93% | 64.65% |
| Total Common Equity | -65.01% | 2.84% | -7.30% | 993.61% | 235.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -65.01% | 2.84% | -7.30% | 993.61% | 235.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -63.40% | 7.83% | -4.76% | 1,015.68% | 235.13% |
|
|
|||||